The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-hydroxy-N8-(4-(2-(4-(piperidin-1-yl)phenylamino)pyrimidin-4-yl)phenyl)octanediamide ID: ALA4285223
Chembl Id: CHEMBL4285223
PubChem CID: 145991731
Max Phase: Preclinical
Molecular Formula: C29H36N6O3
Molecular Weight: 516.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCCCCC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCCCC4)cc3)n2)cc1)NO
Standard InChI: InChI=1S/C29H36N6O3/c36-27(8-4-1-2-5-9-28(37)34-38)31-23-12-10-22(11-13-23)26-18-19-30-29(33-26)32-24-14-16-25(17-15-24)35-20-6-3-7-21-35/h10-19,38H,1-9,20-21H2,(H,31,36)(H,34,37)(H,30,32,33)
Standard InChI Key: FBOSGXMDCDWJBK-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 516.65Molecular Weight (Monoisotopic): 516.2849AlogP: 5.66#Rotatable Bonds: 12Polar Surface Area: 119.48Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.91CX Basic pKa: 6.40CX LogP: 5.19CX LogD: 5.14Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.14Np Likeness Score: -1.11
References 1. Chu-Farseeva YY, Mustafa N, Poulsen A, Tan EC, Yen JJY, Chng WJ, Dymock BW.. (2018) Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat., 158 [PMID:30243158 ] [10.1016/j.ejmech.2018.09.024 ]